ID   PNKP_HUMAN              Reviewed;         521 AA.
AC   Q96T60; Q9BUL2; Q9P1V2; Q9UKU8; Q9UNF8; Q9UNI0;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Bifunctional polynucleotide phosphatase/kinase;
DE   AltName: Full=DNA 5'-kinase/3'-phosphatase;
DE   AltName: Full=Polynucleotide kinase-3'-phosphatase;
DE   Includes:
DE     RecName: Full=Polynucleotide 3'-phosphatase;
DE              EC=3.1.3.32;
DE     AltName: Full=2'(3')-polynucleotidase;
DE   Includes:
DE     RecName: Full=Polynucleotide 5'-hydroxyl-kinase;
DE              EC=2.7.1.78;
GN   Name=PNKP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10446192; DOI=10.1074/jbc.274.34.24176;
RA   Jilani A., Ramotar D., Slack C., Ong C., Yang X.M., Scherer S.W.,
RA   Lasko D.D.;
RT   "Molecular cloning of the human gene, PNKP, encoding a polynucleotide
RT   kinase 3'-phosphatase and evidence for its role in repair of DNA
RT   strand breaks caused by oxidative damage.";
RL   J. Biol. Chem. 274:24176-24186(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND CHARACTERIZATION.
RX   PubMed=10446193; DOI=10.1074/jbc.274.34.24187;
RA   Karimi-Busheri F., Daly G., Robins P., Canas B., Pappin D.J.C.,
RA   Sgouros J., Miller G.G., Fakhrai H., Davis E.M., Le Beau M.M.,
RA   Weinfeld M.;
RT   "Molecular characterization of a human DNA kinase.";
RL   J. Biol. Chem. 274:24187-24194(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Yang H.W., Piao H.Y., Chen Y.Z., Hayashi Y.;
RT   "Cloning a cDNA which is differently expressed in malignancies.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Scorilas A., Katsaros N.;
RT   "Genomic organization, physical mapping and expression analysis of the
RT   human polynucleotide kinase-3'-phosphatase (PNKP) gene.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-20; VAL-63;
RP   SER-180; ASN-196 AND GLY-478.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Blood, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-122, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-118 AND THR-122, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-118 AND THR-122, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-118, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114 AND THR-118, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; THR-118 AND
RP   THR-122, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-118, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   INVOLVEMENT IN AOA4, AND VARIANTS AOA4 TRP-375 AND THR-408 DEL.
RX   PubMed=25728773; DOI=10.1016/j.ajhg.2015.01.005;
RA   Bras J., Alonso I., Barbot C., Costa M.M., Darwent L., Orme T.,
RA   Sequeiros J., Hardy J., Coutinho P., Guerreiro R.;
RT   "Mutations in PNKP cause recessive ataxia with oculomotor apraxia type
RT   4.";
RL   Am. J. Hum. Genet. 96:474-479(2015).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 1-110 ALONE AND IN COMPLEX
RP   WITH XRCC1 PHOSPHOPEPTIDE, AND DOMAIN FHA.
RX   PubMed=19155274; DOI=10.1093/nar/gkn1086;
RA   Ali A.A., Jukes R.M., Pearl L.H., Oliver A.W.;
RT   "Specific recognition of a multiply phosphorylated motif in the DNA
RT   repair scaffold XRCC1 by the FHA domain of human PNK.";
RL   Nucleic Acids Res. 37:1701-1712(2009).
RN   [20]
RP   VARIANTS MCSZ PHE-176 AND LYS-326.
RX   PubMed=20118933; DOI=10.1038/ng.526;
RA   Shen J., Gilmore E.C., Marshall C.A., Haddadin M., Reynolds J.J.,
RA   Eyaid W., Bodell A., Barry B., Gleason D., Allen K., Ganesh V.S.,
RA   Chang B.S., Grix A., Hill R.S., Topcu M., Caldecott K.W.,
RA   Barkovich A.J., Walsh C.A.;
RT   "Mutations in PNKP cause microcephaly, seizures and defects in DNA
RT   repair.";
RL   Nat. Genet. 42:245-249(2010).
RN   [21]
RP   VARIANT MCSZ PRO-462.
RX   PubMed=27232581; DOI=10.1002/ajmg.a.37766;
RA   Nair P., Hamzeh A.R., Mohamed M., Saif F., Tawfiq N., El Halik M.,
RA   Al-Ali M.T., Bastaki F.;
RT   "Microcephalic primordial dwarfism in an Emirati patient with PNKP
RT   mutation.";
RL   Am. J. Med. Genet. A 170:2127-2132(2016).
CC   -!- FUNCTION: Plays a key role in the repair of DNA damage,
CC       functioning as part of both the non-homologous end-joining (NHEJ)
CC       and base excision repair (BER) pathways. Through its two catalytic
CC       activities, PNK ensures that DNA termini are compatible with
CC       extension and ligation by either removing 3'-phosphates from, or
CC       by phosphorylating 5'-hydroxyl groups on, the ribose sugar of the
CC       DNA backbone. {ECO:0000269|PubMed:10446192}.
CC   -!- CATALYTIC ACTIVITY: A 3'-phosphopolynucleotide + H(2)O = a
CC       polynucleotide + phosphate.
CC   -!- CATALYTIC ACTIVITY: ATP + 5'-dephospho-DNA = ADP + 5'-phospho-DNA.
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       O43524:FOXO3; NbExp=2; IntAct=EBI-1045072, EBI-1644164;
CC       Q13422:IKZF1; NbExp=3; IntAct=EBI-1045072, EBI-745305;
CC       Q15025:TNIP1; NbExp=5; IntAct=EBI-1045072, EBI-357849;
CC       O94972:TRIM37; NbExp=3; IntAct=EBI-1045072, EBI-741602;
CC       P18887:XRCC1; NbExp=6; IntAct=EBI-1045072, EBI-947466;
CC       Q13426:XRCC4; NbExp=5; IntAct=EBI-1045072, EBI-717592;
CC       O43829:ZBTB14; NbExp=5; IntAct=EBI-1045072, EBI-10176632;
CC       Q9UID6:ZNF639; NbExp=5; IntAct=EBI-1045072, EBI-947476;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10446193}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96T60-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96T60-2; Sequence=VSP_055500;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues with highest
CC       expression in spleen and testis, and lowest expression in small
CC       intestine (PubMed:10446192). Expressed in higher amount in
CC       pancreas, heart and kidney and at lower levels in brain, lung and
CC       liver (PubMed:10446193). {ECO:0000269|PubMed:10446192,
CC       ECO:0000269|PubMed:10446193}.
CC   -!- DOMAIN: The FHA domain binds threonine-phosphorylated peptides
CC       from XRCC1/4, and is responsible for the recruitment of PNKP to
CC       the sites of DNA repair. The affinity is ten times greater if
CC       peptides are also phosphorylated on the serine preceeding the
CC       phosphothreonine. {ECO:0000269|PubMed:19155274}.
CC   -!- DISEASE: Microcephaly, seizures, and developmental delay (MCSZ)
CC       [MIM:613402]: A disease characterized by infantile-onset seizures,
CC       microcephaly, severe intellectual disability and delayed motor
CC       milestones with absent speech or only achieving a few words. Most
CC       patients also have behavioral problems with hyperactivity.
CC       Microcephaly is progressive and without neuronal migration or
CC       structural abnormalities, consistent with primary microcephaly.
CC       {ECO:0000269|PubMed:20118933, ECO:0000269|PubMed:27232581}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Ataxia-oculomotor apraxia 4 (AOA4) [MIM:616267]: An
CC       autosomal recessive disease characterized by cerebellar ataxia,
CC       oculomotor apraxia, areflexia and peripheral neuropathy.
CC       {ECO:0000269|PubMed:25728773}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the DNA 3'
CC       phosphatase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD47379.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pnkp/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF126486; AAD51135.1; -; mRNA.
DR   EMBL; AF125807; AAD50639.1; -; mRNA.
DR   EMBL; AF120499; AAD47379.1; ALT_FRAME; mRNA.
DR   EMBL; AF354258; AAK57340.1; -; Genomic_DNA.
DR   EMBL; AY133033; AAM82170.1; -; Genomic_DNA.
DR   EMBL; AC018766; AAF44716.1; -; Genomic_DNA.
DR   EMBL; BC002519; AAH02519.2; -; mRNA.
DR   EMBL; BC033822; AAH33822.1; -; mRNA.
DR   CCDS; CCDS12783.1; -. [Q96T60-1]
DR   RefSeq; NP_009185.2; NM_007254.3. [Q96T60-1]
DR   UniGene; Hs.78016; -.
DR   PDB; 2BRF; X-ray; 1.40 A; A=1-110.
DR   PDB; 2W3O; X-ray; 1.85 A; A/B=1-110.
DR   PDBsum; 2BRF; -.
DR   PDBsum; 2W3O; -.
DR   ProteinModelPortal; Q96T60; -.
DR   SMR; Q96T60; -.
DR   BioGrid; 116440; 63.
DR   IntAct; Q96T60; 44.
DR   MINT; MINT-1199136; -.
DR   STRING; 9606.ENSP00000323511; -.
DR   DEPOD; Q96T60; -.
DR   iPTMnet; Q96T60; -.
DR   PhosphoSitePlus; Q96T60; -.
DR   BioMuta; PNKP; -.
DR   DMDM; 50401132; -.
DR   EPD; Q96T60; -.
DR   MaxQB; Q96T60; -.
DR   PaxDb; Q96T60; -.
DR   PeptideAtlas; Q96T60; -.
DR   PRIDE; Q96T60; -.
DR   DNASU; 11284; -.
DR   Ensembl; ENST00000322344; ENSP00000323511; ENSG00000039650. [Q96T60-1]
DR   Ensembl; ENST00000596014; ENSP00000472300; ENSG00000039650. [Q96T60-1]
DR   GeneID; 11284; -.
DR   KEGG; hsa:11284; -.
DR   UCSC; uc002pqj.4; human. [Q96T60-1]
DR   CTD; 11284; -.
DR   DisGeNET; 11284; -.
DR   GeneCards; PNKP; -.
DR   HGNC; HGNC:9154; PNKP.
DR   HPA; HPA006782; -.
DR   MalaCards; PNKP; -.
DR   MIM; 605610; gene.
DR   MIM; 613402; phenotype.
DR   MIM; 616267; phenotype.
DR   neXtProt; NX_Q96T60; -.
DR   OpenTargets; ENSG00000039650; -.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   PharmGKB; PA33477; -.
DR   eggNOG; KOG2134; Eukaryota.
DR   eggNOG; COG0241; LUCA.
DR   GeneTree; ENSGT00570000079163; -.
DR   HOGENOM; HOG000031466; -.
DR   HOVERGEN; HBG053624; -.
DR   InParanoid; Q96T60; -.
DR   KO; K08073; -.
DR   OMA; DIYRKPR; -.
DR   OrthoDB; EOG091G0A9X; -.
DR   PhylomeDB; Q96T60; -.
DR   TreeFam; TF313738; -.
DR   BRENDA; 2.7.1.78; 2681.
DR   BRENDA; 3.1.3.32; 2681.
DR   Reactome; R-HSA-5649702; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway.
DR   SIGNOR; Q96T60; -.
DR   EvolutionaryTrace; Q96T60; -.
DR   GeneWiki; PNKP; -.
DR   GenomeRNAi; 11284; -.
DR   PRO; PR:Q96T60; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000039650; -.
DR   CleanEx; HS_PNKP; -.
DR   ExpressionAtlas; Q96T60; baseline and differential.
DR   Genevisible; Q96T60; HS.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0046404; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; NAS:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; TAS:UniProtKB.
DR   GO; GO:0004519; F:endonuclease activity; NAS:UniProtKB.
DR   GO; GO:0019201; F:nucleotide kinase activity; IDA:UniProtKB.
DR   GO; GO:0046403; F:polynucleotide 3'-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0017076; F:purine nucleotide binding; NAS:UniProtKB.
DR   GO; GO:0016311; P:dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0098504; P:DNA 3' dephosphorylation involved in DNA repair; IBA:GO_Central.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IGI:UniProtKB.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; NAS:UniProtKB.
DR   GO; GO:0046939; P:nucleotide phosphorylation; IDA:UniProtKB.
DR   GO; GO:0000718; P:nucleotide-excision repair, DNA damage removal; NAS:UniProtKB.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IMP:BHF-UCL.
DR   GO; GO:1904355; P:positive regulation of telomere capping; IMP:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IMP:BHF-UCL.
DR   GO; GO:0006979; P:response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:0009314; P:response to radiation; TAS:UniProtKB.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006549; HAD-SF_hydro_IIIA.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR013954; PNK3P.
DR   InterPro; IPR006550; PNK_3Pase_met.
DR   InterPro; IPR006551; Polynucleotide_phosphatase.
DR   InterPro; IPR008984; SMAD_FHA_domain.
DR   Pfam; PF08645; PNK3P; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR01664; DNA-3'-Pase; 1.
DR   TIGRFAMs; TIGR01662; HAD-SF-IIIA; 1.
DR   TIGRFAMs; TIGR01663; PNK-3'Pase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   DNA damage; DNA repair; Epilepsy; Hydrolase; Kinase;
KW   Mental retardation; Multifunctional enzyme; Neurodegeneration;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Primary microcephaly; Reference proteome; Transferase.
FT   CHAIN         1    521       Bifunctional polynucleotide
FT                                phosphatase/kinase.
FT                                /FTId=PRO_0000058478.
FT   DOMAIN        6    110       FHA.
FT   NP_BIND     372    379       ATP. {ECO:0000255}.
FT   REGION      146    337       Phosphatase. {ECO:0000250}.
FT   REGION      341    516       Kinase. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     114    114       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     118    118       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     122    122       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     50       MGEVEAPGRLWLESPPGGAPPIFLPSDGQALVLGRGPLTQV
FT                                TDRKCSRTQ -> MQILTPPLQSS (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055500.
FT   VARIANT      20     20       P -> S (in dbSNP:rs3739168).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019260.
FT   VARIANT      63     63       A -> V (in dbSNP:rs3739173).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019261.
FT   VARIANT     176    176       L -> F (in MCSZ; dbSNP:rs267606957).
FT                                {ECO:0000269|PubMed:20118933}.
FT                                /FTId=VAR_063835.
FT   VARIANT     180    180       R -> S (in dbSNP:rs3739185).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019262.
FT   VARIANT     196    196       Y -> N (in dbSNP:rs3739186).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019263.
FT   VARIANT     326    326       E -> K (in MCSZ; dbSNP:rs267606956).
FT                                {ECO:0000269|PubMed:20118933}.
FT                                /FTId=VAR_063836.
FT   VARIANT     375    375       G -> W (in AOA4; dbSNP:rs786203983).
FT                                {ECO:0000269|PubMed:25728773}.
FT                                /FTId=VAR_073369.
FT   VARIANT     408    408       Missing (in AOA4).
FT                                {ECO:0000269|PubMed:25728773}.
FT                                /FTId=VAR_073370.
FT   VARIANT     462    462       R -> P (in MCSZ; atypical phenotype;
FT                                dbSNP:rs376854895).
FT                                {ECO:0000269|PubMed:27232581}.
FT                                /FTId=VAR_076537.
FT   VARIANT     478    478       V -> G (in dbSNP:rs3739206).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019264.
FT   CONFLICT      6      6       A -> P (in Ref. 2; AAD50639).
FT                                {ECO:0000305}.
FT   CONFLICT     18     18       G -> E (in Ref. 1; AAD51135).
FT                                {ECO:0000305}.
FT   CONFLICT    458    458       R -> C (in Ref. 3; AAD47379).
FT                                {ECO:0000305}.
FT   STRAND        9     13       {ECO:0000244|PDB:2BRF}.
FT   STRAND       31     33       {ECO:0000244|PDB:2BRF}.
FT   TURN         37     40       {ECO:0000244|PDB:2BRF}.
FT   STRAND       51     56       {ECO:0000244|PDB:2BRF}.
FT   TURN         57     60       {ECO:0000244|PDB:2BRF}.
FT   STRAND       61     66       {ECO:0000244|PDB:2BRF}.
FT   STRAND       68     70       {ECO:0000244|PDB:2BRF}.
FT   STRAND       84     88       {ECO:0000244|PDB:2BRF}.
FT   STRAND       92     96       {ECO:0000244|PDB:2BRF}.
FT   STRAND       99    107       {ECO:0000244|PDB:2BRF}.
SQ   SEQUENCE   521 AA;  57076 MW;  22B5C94D41E62516 CRC64;
     MGEVEAPGRL WLESPPGGAP PIFLPSDGQA LVLGRGPLTQ VTDRKCSRTQ VELVADPETR
     TVAVKQLGVN PSTTGTQELK PGLEGSLGVG DTLYLVNGLH PLTLRWEETR TPESQPDTPP
     GTPLVSQDEK RDAELPKKRM RKSNPGWENL EKLLVFTAAG VKPQGKVAGF DLDGTLITTR
     SGKVFPTGPS DWRILYPEIP RKLRELEAEG YKLVIFTNQM SIGRGKLPAE EFKAKVEAVV
     EKLGVPFQVL VATHAGLYRK PVTGMWDHLQ EQANDGTPIS IGDSIFVGDA AGRPANWAPG
     RKKKDFSCAD RLFALNLGLP FATPEEFFLK WPAAGFELPA FDPRTVSRSG PLCLPESRAL
     LSASPEVVVA VGFPGAGKST FLKKHLVSAG YVHVNRDTLG SWQRCVTTCE TALKQGKRVA
     IDNTNPDAAS RARYVQCARA AGVPCRCFLF TATLEQARHN NRFREMTDSS HIPVSDMVMY
     GYRKQFEAPT LAEGFSAILE IPFRLWVEPR LGRLYCQFSE G
//
